Cytosorbents Corp
Specializing in blood purification therapies for critical care to treat life-threatening conditions.
CTSO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US23283X2062
- LEI:
- Country:
- United States of America
- Address:
- 305 COLLEGE ROAD EAST, 8540 PRINCETON
- Website:
- https://cytosorbents.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
CytoSorbents Corporation is a critical care medical company specializing in blood purification to treat life-threatening conditions. The company's core technology is based on proprietary biocompatible, highly porous polymer beads that utilize hemoadsorption to remove excessive levels of harmful substances, such as cytokines and other inflammatory mediators, from the blood. Its flagship product, CytoSorb, is an extracorporeal therapy used in intensive care units and cardiac surgery to control hyperinflammation and prevent organ damage. The product portfolio also includes the PuriFi platform, ECOS for ex vivo organ perfusion, and VetResQ for veterinary emergencies. The company's therapies are distributed in over 75 countries.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Cytosorbents Corp filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Cytosorbents Corp
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Cytosorbents Corp via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
